Human organoid systems reveal in vitro correlates of fitness for SARS-CoV-2 B.1.1.7
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
A new phase of the COVID-19 pandemic has started as several SARS-CoV-2 variants are rapidly emerging globally, raising concerns for increased transmissibility. As animal models and traditional in vitro systems may fail to model key aspects of the SARS-CoV-2 replication cycle, representative in vitro systems to assess variants phenotypically are urgently needed. We found that the British variant (clade B.1.1.7), compared to an ancestral SARS-CoV-2 clade B virus, produced higher levels of infectious virus late in infection and had a higher replicative fitness in human airway, alveolar and intestinal organoid models. Our findings unveil human organoids as powerful tools to phenotype viral variants and suggest extended shedding as a correlate of fitness for SARS-CoV-2.
One-Sentence Summary
British SARS-CoV-2 variant (clade B.1.1.7) infects organoids for extended time and has a higher fitness in vitro .
Article activity feed
-
SciScore for 10.1101/2021.05.03.441080: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: The Medical Ethical Committee of the Erasmus MC Rotterdam granted permission for this study (METC 2012-512).
Consent: Tissue from the ileum was obtained from the UMC Utrecht with informed consent of the patient, who was operated for resection of an intestinal tumor.
IACUC: The study was approved by the UMC Utrecht (Utrecht, The Netherlands) ethical committee and was in accordance with the Declaration of Helsinki and according to Dutch law.Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication Contamination: Cell lines were tested negative for mycoplasma. Table 2: Resources
Antibodies Sentences Resources Next, … SciScore for 10.1101/2021.05.03.441080: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: The Medical Ethical Committee of the Erasmus MC Rotterdam granted permission for this study (METC 2012-512).
Consent: Tissue from the ileum was obtained from the UMC Utrecht with informed consent of the patient, who was operated for resection of an intestinal tumor.
IACUC: The study was approved by the UMC Utrecht (Utrecht, The Netherlands) ethical committee and was in accordance with the Declaration of Helsinki and according to Dutch law.Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication Contamination: Cell lines were tested negative for mycoplasma. Table 2: Resources
Antibodies Sentences Resources Next, cells were incubated in FACS buffer (2mM EDTA, 2.5% bovine serum albumin (BSA) in PBS) on ice for 5 min, stained with the AT2 marker antibody HTII-280 (1:40; Terrace Biotech) on ice for 15 min, and with goat anti-mouse IgM Alexa Fluor 488 (1:400; Invitrogen) for 5 min. AT2suggested: Noneanti-mouse IgMsuggested: NoneCells were incubated with primary antibodies overnight at 4°C in blocking buffer, washed twice with PBS, incubated with corresponding secondary antibodies (Alexa 488-/ 594-conjugated anti-rabbit IgG, anti-mouse IgG, or anti-mouse IgG1 (1:500; Invitrogen)) in blocking buffer for 2 hours at room temperature, washed two times with PBS, incubated with indicated additional stains (hoechst (ThermoFisher) or phalloidin (Santa Cruz)), washed twice with PBS, and mounted in Prolong Antifade (Invitrogen) mounting medium. anti-mouse IgGsuggested: NoneAntifade ( Invitrogen ) mounting medium .suggested: NoneFor ACE2 stainings, cells were blocked with 1% BSA and stained overnight with goat anti-ACE2 (1:200, R&D Systems) in blocking buffer followed by rabbit anti-goat Alexa Fluor 488 (1:500, Invitrogen) in blocking buffer for 2 hours at room temperature, washed two times with PBS, incubated with indicated additional stains (hoechst or phalloidin), washed twice with PBS, and mounted in Prolong Antifade mounting medium 3D Alveolar and airway organoids were fixed in 4% formalin overnight, permeabilized in 0.1% Triton X-100, and blocked for 60 min in 10% normal goat serum in PBS (blocking buffer). anti-ACE2suggested: NoneCells were incubated with primary antibodies overnight at 4°C in blocking buffer, washed twice with PBS, incubated with corresponding secondary antibodies (Alexa488- and 594-conjugated anti-rabbit IgG, anti-mouse IgG, or anti-mouse IgG1 (1:500; Invitrogen)) in blocking buffer for 2 hours at room temperature, washed two times with PBS, incubated with indicated additional stains (hoechst or phalloidin), washed twice with PBS, and mounted in Prolong Antifade mounting medium. anti-rabbit IgGsuggested: Noneanti-mouse IgG1suggested: NoneAntifade mounting medium .suggested: NoneExperimental Models: Cell Lines Sentences Resources Calu-3 cells were maintained in Opti-MEM I (1) + GlutaMAX (Gibco) supplemented with 10% FBS, penicillin (100 IU/mL), and streptomycin (100 IU/mL) at 37°C in a humidified CO2 incubator. Calu-3suggested: NoneRNA copies per ml were determined by qRT-PCR using primers targeting the E gene (52) and comparing the Ct values to a counted standard curve derived from a Bavpat-1 stock titrated on VeroE6 cells. VeroE6suggested: JCRB Cat# JCRB1819, RRID:CVCL_YQ49)Software and Algorithms Sentences Resources Raw deep-sequencing data are available at the NIH Short Read Archive under accession number: BioProject PRJNA722947. BioProjectsuggested: (NCBI BioProject, RRID:SCR_004801)At 3 days postinfection light microscopy images were taken of VeroE6 infected cultures using a Zeiss Primovert microscope and analysed using ZEN software (Zeiss). ZENsuggested: NonePlaque assay analysis was performed using ImageQuant TL 8.2 software (GE Healthcare). ImageQuantsuggested: (ImageQuant, RRID:SCR_014246)Briefly, sequencing adapters from the paired-end sequencing reads were trimmed by cutadapt (54), and aligned to the corresponding genome (Bavpat-1 and B.1.1.7 isolate consensus sequence) using Bowtie2 (55) with the parameters: --no-discordant --dovetail --no-mixed -- maxins 2000. Bowtie2suggested: (Bowtie 2, RRID:SCR_016368)Variant calling was performed by VarScan2 (57) with parameters: pileup2cns --min-coverage 10 --min-reads2 2 --min-var-freq 0.01 --min- freq-for-hom 0.75 --p-value 0.05 --variants 1 using pileup data from SAMtools mpileup (58) with parameters: --excl-flags 2048 --excl-flags 256 --max-depth 50000 --min-MQ 30 --min-BQ 30. SAMtoolssuggested: (SAMTOOLS, RRID:SCR_002105)Raw sequencing data are available at the NIH Short Read Archive under accession number: BioProject PRJNA722947. Short Read Archivesuggested: NoneRead 2 was aligned to the CRCh38 human RefSeq transcriptome, with the addition of SARS-CoV-2 (Ref-SKU: 026V-03883; MW947280) genomes, using BWA using standard settings (62). BWAsuggested: (BWA, RRID:SCR_010910)Differential expression analysis were performed using the DESeq2 package (63). DESeq2suggested: (DESeq, RRID:SCR_000154)Data was stitched, uploaded, shared and annotated using Omero (annotated using Omero) and PathViewer. Omerosuggested: (OMERO, RRID:SCR_002629)Statistical analysis: Statistical analysis was performed with the GraphPad Prism 9 software. GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: Thank you for sharing your code and data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-